Leap Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $87,041,000.
Profit Margin
| 2014 | 0 | -25.45M | |
|---|---|---|---|
| 2015 | 0 | -21.10M | |
| 2016 | 0 | -25.63M | |
| 2017 | 0 | -29.72M | |
| 2018 | 0 | -23.13M | |
| 2019 | 0 | -32.9M | |
| 2020 | 1.5M | -27.51M | -1834.27% |
| 2021 | 1.5M | -40.58M | -2705.8% |
| 2022 | 0 | -54.59M | |
| 2023 | 0 | -81.41M |
LPTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 1.5M | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 427K | 415K | 0 | 0 | 776K | 49K | 48K | 25K | 0 | 0 |
Gross profit | -427K | -415K | 1.5M | 1.5M | -776K | -49K | -48K | -25K | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 73.23M | 44.96M | 32.16M | 20.42M | 24.36M | 21.07M | 22.50M | 23.29M | 15.36M | 15.54M |
Selling and marketing | -427K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 87.04M | 54.71M | 41.7M | 29.80M | 33.31M | 29.99M | 32.35M | 27.52M | 21.08M | 20.25M |
Operating income | -87.04M | -56.76M | -41.42M | -28.53M | -33.45M | -30.75M | -32.35M | -27.52M | -21.08M | -20.91M |
Other income (expenses), net | 5.62M | 2.31M | 815K | 1.02M | 548K | 6.44M | 2.46M | 3.12M | 9.03M | -4.50M |
Income before tax | -81.41M | -54.44M | -40.61M | -27.51M | -32.90M | -23.11M | -29.88M | -25.63M | -20.95M | -25.42M |
Income tax expense | 0 | 147K | -24K | -2K | -3K | 20K | -157K | 4.35M | 152K | 31K |
Net income | -81.41M | -54.59M | -40.58M | -27.51M | -32.9M | -23.13M | -29.72M | -25.63M | -21.10M | -25.45M |
Earnings per share | ||||||||||
Basic EPS | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.36 | -32.45 | -27.29 | -12.37 | -21.45 |
Diluted EPS | -3.98 | -4.82 | -4.73 | -4.64 | -14.57 | -16.05 | -32.35 | -27.29 | -12.37 | -21.45 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |